HomeLocal NewsUrgent Recall: Popular Baby Food Brand Pulled from Shelves Nationwide Over Health...

Urgent Recall: Popular Baby Food Brand Pulled from Shelves Nationwide Over Health Concerns

Share and Follow

A baby food product available in Connecticut and across 48 other states is being recalled due to a potential health hazard, as reported by the FDA.

Initiative Foods has announced a recall of its Tippy Toes brand Apple Pear Banana Fruit puree because of heightened levels of patulin. According to the FDA, patulin is a naturally occurring toxin produced by molds that can develop in various fruits.

  • Thousands fill Ybor City for annual Illuminated Knight Parade

Exposure to elevated levels of patulin over time may result in several health issues, such as immune system suppression, nerve damage, headaches, fever, and nausea, according to FDA warnings.

This product has been distributed throughout the United States, except for Alaska, and it might also be available in the U.S. territories of Guam and Puerto Rico.

A baby food sold in Connecticut and 48 other states has been recalled due to a possible health risk, according to the FDA.
A baby food sold in Connecticut and 48 other states has been recalled due to a possible health risk, according to the FDA.

The specific batch affected bears the lot number 07174 and a “Best By” date of July 17, 2026. The packages involved in the recall are also identified with the code “INIA0120.”

Customers are urged to check their products. If customers do have products with the July 17, 2026 “Best By” date, they are advised to dispose of them and contact a healthcare provider if concerns arise.

Retailers are advised to remove the affected product immediately.

“At Initiative Foods, the safety of our consumers and their families is our highest priority. We are cooperating with the FDA to ensure strict review and enhanced safety measures across all our products. We thank our retail partners and customers for their understanding and prompt action on this matter,” Initiative Foods’ CEO and president Don Ephgrave said.

No illnesses or injuries have been reported to date, the FDA said.

Share and Follow